Announcements Trials
Browse Landscape

Phase

Phase 1 7Phase 2 5Phase 3 4Phase 1/2 2Phase 4 1Phase 2/3 1

Status

Completed 5Terminated 4Active not recruiting 3Withdrawn 1Unknown 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 3Thoracic 1Breast 1

Conditions

Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Prostate Cancer Metastatic 1Carcinoma, Transitional Cell 1Breast Neoplasms 1

Interventions

Cyclophosphamide 741Cisplatin 688Gemcitabine 641Bevacizumab 616Carboplatin 605Paclitaxel 601Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 361Capecitabine 342Filgrastim 333Etoposide 330Dexamethasone 312Irinotecan 309pembrolizumab 282Leucovorin 274Cetuximab 268Cytarabine 242Erlotinib Hydrochloride 231Nivolumab 228Prednisone 227Trastuzumab 225Vincristine 221Bortezomib 221Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Completed × XRP6258 × Clear all
NCT01437488 2025-05-04

Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy

Thomas Jefferson University

Phase 2 Completed
14 enrolled 12 charts
Genitourinary

Carcinoma, Transitional Cell

NCT01718353 2017-11-20

TAXYNERGY

Sanofi

Phase 2 Completed
63 enrolled 13 charts
Genitourinary

Prostate Cancer Metastatic

NCT01693549 2017-08-01

Study of Cabazitaxel in Patients With Metastatic Breast Cancer Previously Treated With Taxanes

Hellenic Cooperative Oncology Group

Phase 2 Completed
84 enrolled
Breast

Breast Neoplasms

NCT01500720 2015-04-13

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

Sanofi

Phase 2 Completed
179 enrolled 16 charts
Thoracic

Small Cell Lung Carcinoma

NCT01576029 2013-12-24

SWITCH

Sanofi

Phase 2 Completed
2 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡